Mireia Beltran Porres

Dr. Mireia Beltran Porres


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2025 in Genes
Verified
Journal Article
Open access
PDF file
EMEmma Fortes Marin
Emma Fortes Marin
LMLydia Carrera Marcolin
Lydia Carrera Marcolin
LMLaia Martí Melero
Laia Martí Melero
MTMaria Tintoré
Maria Tintoré
MPMireia Beltran Porres
Mireia Beltran Porres
Background/Objectives: The prevalence of the diamine oxidase (DAO) enzyme deficiency of a genetic origin has not been previously assessed. A prospective population-based study was conducted in a sample of 200 healthy newborns aimed to determine the prevalence of DAO enzyme deficiency caused by single nucleotide polymorphism (SNP) variants of the AOC1 gene. Methods: Genotyping was performed in oral mucosa samples collected around 2 days after birth. The four more frequent SNPs, c.47C>T (rs10156191), c.995C>T (rs1049742), c.1990C>G (rs10449793), and c.691G>T (rs2052129), were analyzed. Results: DAO deficiency was present in 132 newborns, with a prevalence of 66% (95% confidence interval [CI] 59–73%). The rs10449793 variant showed a prevalence of 46%, followed by rs10156191 with a prevalence of 42.5%, and rs2052129 with a prevalence of 39.5%. The variant rs1049742 showed the lowest prevalence (9.5%). The frequency of one, two, three, or four SNPs was 23%, 23.5%, 10.5%, and 9%, respectively. In all fours SNP variants, heterozygous carriers were more frequent than homozygous carriers (19% homozygosity). Differences in the prevalence of DAO deficiency between males (68%, 66/96) and females (63.4%, 66/104) were not found (p = 0.885). The prevalence in Caucasian newborns was 66.5% (123/185), as compared with 60% (9/15) in Latin Americans (p = 0.821). Conclusions: This study carried out in healthy newborns indicates that there is a high prevalence (66%) of DAO deficiency of a genetic origin in the general population.

19 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
EMEmma Fortes Marin
Emma Fortes Marin
LMLydia Carrera Marcolin
Lydia Carrera Marcolin
LMLaia Martí Melero
Laia Martí Melero
MTMaria Tintoré
Maria Tintoré
MPMireia Beltran Porres
Mireia Beltran Porres
A prospective population-based study was conducted in a sample of 200 healthy newborns aimed to determine the prevalence of diamine oxidase (DAO) enzyme deficiency caused by single nucleotide polymorphisms (SNPs) variants of the AOC1 gene. Genotyping was performed in oral mucosa samples collected around 2 days after birth. The four more frequent SNPs, c.47C>T (rs10156191), c.995C>T (rs1049742), c.1990C>G (rs10449793) and c.691G>T (re2052129) were analyzed. DAO deficiency was present in 132 newborns, with a prevalence of 66% (95% confidence interval [CI] 59-73%). The rs10449793 variant showed a prevalence of 46%, followed by rs10156191 with a prevalence of 42.5%, and rs2052129 with a prevalence of 39.5%. The variant rs1049742) showed the lowest prevalence (9.5%). The frequency of one, two, three, or four SNPs was 23%, 23.5%, 10.5%, and 9%, respectively. In all fours SNPs variants, heterozygous carriers were more frequent than homozygous carriers (19% homozygosity). Differences in the prevalence of DAO deficiency between males (68%, 66/96) and females (63.4%, 66/104) were not found (p = 0.885). The prevalence in Caucasian newborns was 66.5% (123/185) as compared with 60% (9/15) in Latin Americans (p = 0.821). In the general population, there is a high prevalence (66%) of DAO deficiency of genetic origin.